tiprankstipranks
Trending News
More News >
UnitedHealth (DE:UNH)
XETRA:UNH
Germany Market
Advertisement

UnitedHealth (UNH) Stock Forecast & Price Target

Compare
68 Followers
See the Price Targets and Ratings of:

UNH Analyst Ratings

Moderate Buy
22Ratings
Moderate Buy
18 Buy
2 Hold
2 Sell
Based on 22 analysts giving stock ratings to
UnitedHealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

€310.55
▲(0.63% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is €310.55 with a high forecast of €379.41 and a low forecast of €170.73. The average price target represents a 0.63% change from the last price of €308.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"169":"€169","368":"€368","567":"€567","268.5":"€268.5","467.5":"€467.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":379.4074856,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€379.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":310.5450269636,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€310.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":170.73336852,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€170.73</span>\n  </div></div>","useHTML":true}}],"tickPositions":[169,268.5,368,467.5,567],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,297.45,303.75442196923075,310.0588439384615,316.36326590769227,322.6676878769231,328.97210984615384,335.2765318153846,341.58095378461536,347.8853757538461,354.1897977230769,360.49421969230764,366.79864166153845,373.1030636307692,{"y":379.4074856,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,297.45,298.45730976643074,299.46461953286155,300.4719292992923,301.47923906572305,302.48654883215386,303.4938585985846,304.50116836501536,305.5084781314461,306.5157878978769,307.52309766430767,308.5304074307384,309.53771719716923,{"y":310.5450269636,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,297.45,287.70256680923075,277.9551336184615,268.2077004276923,258.4602672369231,248.71283404615383,238.9654008553846,229.21796766461537,219.47053447384616,209.72310128307691,199.97566809230767,190.22823490153846,180.4808017107692,{"y":170.73336852,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":520.312,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":513.949,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":566.616,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":476.949,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":514.734,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":446.977,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":480.671,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":356.321,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":261.727,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 72,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.049,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.754,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":263.962,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€379.41Average Price Target€310.55Lowest Price Target€170.73
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on DE:UNH
Jefferies
Jefferies
€352.68
Buy
14.28%
Upside
Reiterated
10/16/25
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH) and Veeva Systems (NYSE: VEEV)We remain Buy rated on the expectation that fundamentals news, particularly mgn expansion, is meaningful more positive than expectations. However, we recognize only modestly positive news likely doesn't justify current valuation. New PT $409, which is 17.0x our '27 EPS of $24.01.
Bernstein Analyst forecast on DE:UNH
Bernstein
Bernstein
€373.37
Buy
20.99%
Upside
Reiterated
10/16/25
Bernstein Reaffirms Their Buy Rating on UnitedHealth (UNH)
TD Cowen
€237.13€288.87
Hold
-6.39%
Downside
Reiterated
10/16/25
Cautious Hold on UnitedHealth Amid Medicare Advantage Uncertainties and Raised Price Target
RBC Capital Analyst forecast on DE:UNH
RBC Capital
RBC Capital
€246.61
Buy
-20.09%
Downside
Reiterated
10/15/25
UnitedHealth (UNH) Gets a Buy from RBC Capital
Truist Financial Analyst forecast on DE:UNH
Truist Financial
Truist Financial
€314.74€353.54
Buy
14.56%
Upside
Reiterated
10/14/25
UnitedHealth price target raised to $410 from $365 at TruistUnitedHealth price target raised to $410 from $365 at Truist
Goldman Sachs Analyst forecast on DE:UNH
Goldman Sachs
Goldman Sachs
€350.09
Buy
13.44%
Upside
Reiterated
10/14/25
Goldman Sachs Sticks to Their Buy Rating for UnitedHealth (UNH)
Cantor Fitzgerald Analyst forecast on DE:UNH
Cantor Fitzgerald
Cantor Fitzgerald
€379.41
Buy
22.94%
Upside
Reiterated
10/10/25
UnitedHealth (UNH) Gets a Buy from Cantor FitzgeraldCantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $440.00 price target on UnitedHealth Group (NYSE: UNH).
J.P. Morgan Analyst forecast on DE:UNH
J.P. Morgan
J.P. Morgan
€267.31€366.47
Buy
18.75%
Upside
Reiterated
10/09/25
UnitedHealth (UNH) Gets a Buy from J.P. Morgan
Barclays
€303.53€332.84
Buy
7.86%
Upside
Reiterated
10/09/25
UnitedHealth (UNH) Gets a Buy from Barclays
Mizuho Securities Analyst forecast on DE:UNH
Mizuho Securities
Mizuho Securities
€258.69€370.78
Buy
20.15%
Upside
Reiterated
10/08/25
UnitedHealth price target raised to $430 from $300 at MizuhoUnitedHealth price target raised to $430 from $300 at Mizuho
Bank of America Securities Analyst forecast on DE:UNH
Bank of America Securities
Bank of America Securities
€336.29
Hold
8.97%
Upside
Reiterated
10/08/25
UnitedHealth's Earnings Outlook: Balancing Potential Upside with Uncertainty
KeyBanc
€301.8€344.92
Buy
11.77%
Upside
Reiterated
10/08/25
UnitedHealth price target raised to $400 from $350 at KeyBancUnitedHealth price target raised to $400 from $350 at KeyBanc
HSBC
€224.2
Sell
-27.35%
Downside
Reiterated
10/08/25
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and UnitedHealth (NYSE: UNH)
UBS
€325.95
Buy
5.62%
Upside
Assigned
10/06/25
UnitedHealth (UNH) Receives a Buy from UBS
Wells Fargo Analyst forecast on DE:UNH
Wells Fargo
Wells Fargo
€230.23€344.92
Buy
11.77%
Upside
Reiterated
10/06/25
UnitedHealth price target raised to $400 from $267 at Wells FargoUnitedHealth price target raised to $400 from $267 at Wells Fargo
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on DE:UNH
Jefferies
Jefferies
€352.68
Buy
14.28%
Upside
Reiterated
10/16/25
Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH) and Veeva Systems (NYSE: VEEV)We remain Buy rated on the expectation that fundamentals news, particularly mgn expansion, is meaningful more positive than expectations. However, we recognize only modestly positive news likely doesn't justify current valuation. New PT $409, which is 17.0x our '27 EPS of $24.01.
Bernstein Analyst forecast on DE:UNH
Bernstein
Bernstein
€373.37
Buy
20.99%
Upside
Reiterated
10/16/25
Bernstein Reaffirms Their Buy Rating on UnitedHealth (UNH)
TD Cowen
€237.13€288.87
Hold
-6.39%
Downside
Reiterated
10/16/25
Cautious Hold on UnitedHealth Amid Medicare Advantage Uncertainties and Raised Price Target
RBC Capital Analyst forecast on DE:UNH
RBC Capital
RBC Capital
€246.61
Buy
-20.09%
Downside
Reiterated
10/15/25
UnitedHealth (UNH) Gets a Buy from RBC Capital
Truist Financial Analyst forecast on DE:UNH
Truist Financial
Truist Financial
€314.74€353.54
Buy
14.56%
Upside
Reiterated
10/14/25
UnitedHealth price target raised to $410 from $365 at TruistUnitedHealth price target raised to $410 from $365 at Truist
Goldman Sachs Analyst forecast on DE:UNH
Goldman Sachs
Goldman Sachs
€350.09
Buy
13.44%
Upside
Reiterated
10/14/25
Goldman Sachs Sticks to Their Buy Rating for UnitedHealth (UNH)
Cantor Fitzgerald Analyst forecast on DE:UNH
Cantor Fitzgerald
Cantor Fitzgerald
€379.41
Buy
22.94%
Upside
Reiterated
10/10/25
UnitedHealth (UNH) Gets a Buy from Cantor FitzgeraldCantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $440.00 price target on UnitedHealth Group (NYSE: UNH).
J.P. Morgan Analyst forecast on DE:UNH
J.P. Morgan
J.P. Morgan
€267.31€366.47
Buy
18.75%
Upside
Reiterated
10/09/25
UnitedHealth (UNH) Gets a Buy from J.P. Morgan
Barclays
€303.53€332.84
Buy
7.86%
Upside
Reiterated
10/09/25
UnitedHealth (UNH) Gets a Buy from Barclays
Mizuho Securities Analyst forecast on DE:UNH
Mizuho Securities
Mizuho Securities
€258.69€370.78
Buy
20.15%
Upside
Reiterated
10/08/25
UnitedHealth price target raised to $430 from $300 at MizuhoUnitedHealth price target raised to $430 from $300 at Mizuho
Bank of America Securities Analyst forecast on DE:UNH
Bank of America Securities
Bank of America Securities
€336.29
Hold
8.97%
Upside
Reiterated
10/08/25
UnitedHealth's Earnings Outlook: Balancing Potential Upside with Uncertainty
KeyBanc
€301.8€344.92
Buy
11.77%
Upside
Reiterated
10/08/25
UnitedHealth price target raised to $400 from $350 at KeyBancUnitedHealth price target raised to $400 from $350 at KeyBanc
HSBC
€224.2
Sell
-27.35%
Downside
Reiterated
10/08/25
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and UnitedHealth (NYSE: UNH)
UBS
€325.95
Buy
5.62%
Upside
Assigned
10/06/25
UnitedHealth (UNH) Receives a Buy from UBS
Wells Fargo Analyst forecast on DE:UNH
Wells Fargo
Wells Fargo
€230.23€344.92
Buy
11.77%
Upside
Reiterated
10/06/25
UnitedHealth price target raised to $400 from $267 at Wells FargoUnitedHealth price target raised to $400 from $267 at Wells Fargo
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

1 Month
xxx
Success Rate
26/35 ratings generated profit
74%
Average Return
+2.46%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 74.29% of your transactions generating a profit, with an average return of +2.46% per trade.
3 Months
xxx
Success Rate
25/35 ratings generated profit
71%
Average Return
+3.95%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +3.95% per trade.
1 Year
Scott FidelGoldman Sachs
Success Rate
36/44 ratings generated profit
82%
Average Return
+21.31%
reiterated a buy rating 11 days ago
Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +21.31% per trade.
2 Years
xxx
Success Rate
39/44 ratings generated profit
89%
Average Return
+44.42%
assigned a xxx
rating 19 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 88.64% of your transactions generating a profit, with an average return of +44.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
4
5
1
1
0
Buy
68
60
51
52
40
Hold
17
17
11
10
6
Sell
1
2
2
2
2
Strong Sell
0
0
0
0
0
total
90
84
65
65
48
In the current month, UNH has received 40 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. UNH average Analyst price target in the past 3 months is 310.55.
Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is €2.44 with a range of €1.92 to €3.08. The previous quarter’s EPS was €3.53. UNH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year UNH has Preformed in-line its overall industry.
Next quarter’s earnings estimate for UNH is €2.44 with a range of €1.92 to €3.08. The previous quarter’s EPS was €3.53. UNH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year UNH has Preformed in-line its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is €97.69B with a range of €95.01B to €99.07B. The previous quarter’s sales results were €96.46B. UNH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year UNH has Preformed in-line its overall industry.
Next quarter’s sales forecast for UNH is €97.69B with a range of €95.01B to €99.07B. The previous quarter’s sales results were €96.46B. UNH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year UNH has Preformed in-line its overall industry.

UNH Stock Forecast FAQ

What is DE:UNH’s average 12-month price target, according to analysts?
Based on analyst ratings, UnitedHealth’s 12-month average price target is 310.55.
    What is DE:UNH’s upside potential, based on the analysts’ average price target?
    UnitedHealth has 0.63% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UnitedHealth a Buy, Sell or Hold?
          UnitedHealth has a consensus rating of Moderate Buy, which is based on 18 buy ratings, 2 hold ratings and 2 sell ratings.
            What is UnitedHealth’s share price target?
            The average share price target for UnitedHealth is 310.55. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €379.41 ,and the lowest forecast is €170.73. The average share price target represents 0.63% Increase from the current price of €308.6.
              What do analysts say about UnitedHealth?
              UnitedHealth’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of UnitedHealth?
                To buy shares of DE:UNH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis